Pyrrolidine

Pyrrolidine

SCHEMBL5739616

C1CCNC1.CCc1cc(C)c(N)cc1C

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
HSD17B10 Q99714 2/20 0.42
CYP1A2 P05177 1/20 0.42
ALOX15 P16050 1/20 0.42
CASP7 P55210 1/20 0.42
HIF1A Q16665 1/20 0.42
CYP3A4 P08684 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
ESR1 P03372 1/20 0.32
KDM4E B2RXH2 1/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
HTT P42858 1/20 0.31
CHEK1 O14757 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28656722 0.84 ALDH1A1 (0.70) ALDH1A1HSD17B10CYP1A2ALOX15CASP7
SCHEMBL14036541 0.76 ALDH1A1 (0.56) ALDH1A1HSD17B10CYP1A2ALOX15CASP7
Diethylamine SCHEMBL5988480 0.76 ALDH1A1 (0.57) ALDH1A1HSD17B10CYP1A2ALOX15CASP7
SCHEMBL5951712 0.74 ALDH1A1 (0.52) ALDH1A1HSD17B10CYP1A2ALOX15CASP7
SCHEMBL12345636 0.72 ALDH1A1 (0.56) ALDH1A1HSD17B10CYP1A2ALOX15CASP7
SCHEMBL12797863 0.72 ALDH1A1 (0.50) ALDH1A1HSD17B10CYP1A2ALOX15CASP7
SCHEMBL11513154 0.72 ALDH1A1 (0.50) ALDH1A1HSD17B10CYP1A2ALOX15CASP7
SCHEMBL31123471 0.72 ALDH1A1 (0.70) ALDH1A1HSD17B10CYP1A2ALOX15CASP7
Piperidine SCHEMBL11782163 0.71 MAPK1 (0.41) ALDH1A1HSD17B10CYP1A2ALOX15CASP7
SCHEMBL1771694 0.70 HTR2C (0.44) ALDH1A1HSD17B10CYP1A2ALOX15CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644362-A2 INDOLINONE HYDRAZIDES AS C-MET INHIBITORS Sugen, Inc. (US) 2006-04-12 EP disclosed
US-20060009493-A1 Indolinone hydrazides as c-Met inhibitors SUGEN, INC. 2006-01-12 US disclosed
WO-2005005378-A2 INDOLINONE HYDRAZIDES AS C-MET INHIBITORS SUGEN, INC. (US) 2005-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060009493-A1 Indolinone hydrazides as c-Met inhibitors MET, IGF1R, ROS1 ALDH1A1 143/4885HSD17B10 3197/4885CYP1A2 966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.